In the coming days and weeks, Wall Street will be monitoring company results closely. The «Magnificent Seven» are likely to attract particular attention as their shares have risen sharply in 2023.
Bonus Certificate Nestlé, Novartis und Roche
«ZKB Favourite Stocks 2024»: Building Exposure with Reverse Convertibles
The research at Zürcher Kantonalbank has identified ten equity top picks for the new year. The tracker certificate on the «ZKB Favourite Stocks 2024» allows investors to participate in this selection.
A few trading days remain until the end of the year. After the loss-making previous year, the Swiss Market Index is set to post a positive performance.
The shares of Basel-based pharmaceutical group Roche remain a source of concern for investors this year. We think the outlook for 2024 is slightly better. However, the shares remain exposed to risk.
In the past, European luxury goods companies were among the stock market favourites. This year has been different.
US retailers had a strong start to the holiday shopping season. However, it is unclear whether the momentum will continue in the coming weeks.
The shares of the Swiss luxury goods group have lost some of their lustre in recent months. The dry spell is not over yet, but the price correction also opens up opportunities.
Apple's Vision Pro headset is set to shake up the reality technology market. The initial buzz has died down, so now seems a good time to take a closer look at the potential beneficiaries of this new product category.
ZKB Callable Barrier Reverse Convertible on worst of SunPower Corp/Sunrun Inc 127344767 / CH1273447677 |
ZKB Autocallable Barrier Reverse Convertible auf Affirm Holdings Inc 127344951 / CH1273449517 |
ZKB Barrier Reverse Convertible auf Varta AG 132910873 / CH1329108737 |
ZKB Barrier Reverse Convertible on worst of Roche Hldg G / Nestlé N Roche Holding AG/Nestlé AG 113978689 / CH1139786896 |
ZKB Autocallable Barrier Reverse Convertible auf ON Holding AG 127345566 / CH1273455662 |